| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01281254 2009-017946-30 Details | 2017-12-02 Interventional | 3 | 223 | Trebananib Carcinoma, Ovar… Fallopian Tube … Ovarian Neoplas… Fallopian Tube … Ovarian Cancer Primary Periton… | Closure of long term follow up (LTFU) and study earlier than previously outlined in the
protocol as no beneficial information gained from continuing LTFU. - | |||
| NCT01190722 Details | 2017-12-02 Interventional | 4 | 0 | Diclofenac Etoricoxib Bunion Hallux Valgus Pain, Postopera… Postoperative P… | The study site was closed down - | |||
| NCT01163201 Details | 2017-12-02 Interventional | 1/2 | 0 | Cyclophosphamid… Fludarabine Anemia, Refract… Anemia, Refract… Blast Crisis Burkitt Lymphom… Hematologic Neo… Leukemia Leukemia, Lymph… Leukemia, Lymph… Leukemia, Myelo… Leukemia, Myelo… Lymphoma Lymphoma, B-Cel… Lymphoma, Mantl… Lymphoma, Non-H… Myeloproliferat… Neoplasms Precursor Cell … Waldenstrom Mac… Acute Lymphocyt… Acute Myeloid L… Anemia, Refract… Burkitt's Lymph… Chronic Lymphoc… Chronic Myeloge… Chronic Myelopr… Follicular Lymp… Hematologic Mal… High Grade Non-… Large Cell Non-… Lymphoblastic L… Lymphoplasmacyt… Mantle-Cell Lym… Marginal Zone B… Prolymphocytic … Small Lymphocyt… | Replaced by a new study - | |||
| NCT00664209 Details | 2017-12-02 Interventional | 3 | 64 | Amoxicillin Omeprazole Helicobacter In… Parkinson Disea… Motor Fluctuati… Parkinson's Dis… | Prevalence of H Pylori in the study population was much lower than anticipated Screening yield was much lower than anticipated based on the literature which prohibited completion of the study | |||
| NCT00314613 Details | 2017-12-02 Interventional | 4 | - | Antipsychotic A… Risperidone Schizophrenia | - - | |||
| NCT02947113 2016-003790-18 Details | 2017-11-30 Interventional | 2 | 0 | Etoposide Pemetrexed Carcinoma, Non-… Non-Small Cell … | New studies available with immunotherapy so recruitment is no longer acceptable. - | |||
| NCT01381562 Details | 2017-11-29 Interventional | 2 | 15 | Meropenem Communicable Di… Infections Intraabdominal … Infections, Int… | Microbiological findings of resistance on therapy in patients with complicated urinary tract
infection This study was terminated early because only 15 participants were enrolled. | |||
| NCT00702793 Details | 2017-11-29 Interventional | 4 | 0 | Varenicline Mental Disorder… Psychotic Disor… Schizophrenia Psychosis Schizoaffective | No participants enrolled - | |||
| NCT00618696 Details | 2017-11-29 Interventional | 1 | 4 | Antibodies Antibodies, Mon… Antineoplastic … Immunoglobulins Leukemia Myelodysplastic… Preleukemia | Replaced with another study - | |||
| NCT00005993 Details | 2017-11-29 Interventional | 1 | - | Aldesleukin Breast Neoplasm… Lymphoma Breast Cancer | - - | |||
| NCT00929669 Details | 2017-11-28 Interventional | 2 | 2 | Pasireotide Adenoma Gonadotroph Ade… | unable to identify a third subject This trial was terminated due to difficulty in identifying 3 subjects for completion of the study. | |||
| NCT00119184 Details | 2017-11-28 Interventional | 1 | 140 | Anesthetics Breech Presenta… | Multiparas study terminated due to poor recruitment. Randomization revealed only after decision
recorded on clinicaltrials.gov - | |||
| NCT02299765 Details | 2017-11-27 Interventional | 4 | 61 | Carboplatin Gefitinib Gemcitabine Carcinoma, Non-… EGFR Activating… Non-small Cell … | the research data is not statistically significant - | |||
| NCT02176122 Details | 2017-11-27 Interventional | 4 | 391 | Meropenem Piperacillin Piperacillin, T… Tazobactam Infections Sepsis Bloodstream Inf… | Secondary to third interim analysis by the study DSMB. - | |||
| NCT02912169 Details | 2017-11-24 Interventional | 1/2 | 0 | Anesthetics Alzheimer Disea… Alzheimer's Dis… | company dissolved - | |||
| NCT02719015 Details | 2017-11-24 Interventional | 1/2 | 0 | Pembrolizumab Melanoma | No IND Serial # - | |||
| NCT01969565 Details | 2017-11-24 Interventional | 2 | 1 | Dexamethasone Multiple Myelom… Neoplasms, Plas… | Logistical reasons One patient consented but withdrew prior to beginning treatment. | |||
| NCT01559051 Details | 2017-11-24 Interventional | 1/2 | 0 | Anesthetics Lung Diseases Lung Diseases, … Pulmonary Disea… Chronic Obstruc… | company dissolved - | |||
| NCT02847702 Details | 2017-11-22 Interventional | 2 | 75 | Naproxen Osteoarthritis Osteoarthritis … | Company decision - | |||
| NCT02122003 Details | 2017-11-22 Interventional | 2 | 16 | Sorafenib Carcinoma Carcinoma, Rena… Metastatic Rena… | availability of new and more promising therapeutic agents than expected in the experimentation
in question - |